Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Compare Efficacy of Oxytocin Administrations on Postpartum Uterine Contractility

Trial Profile

Compare Efficacy of Oxytocin Administrations on Postpartum Uterine Contractility

Status: Discontinued
Phase of Trial: Phase I

Latest Information Update: 05 Nov 2021

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Oxytocin (Primary) ; Oxytocin (Primary)
  • Indications Postpartum haemorrhage
  • Focus Therapeutic Use
  • Sponsors Oxytone Bioscience

Most Recent Events

  • 20 Nov 2019 Status changed from suspended to discontinued.
  • 13 Mar 2019 Planned End Date changed from 1 Apr 2019 to 1 Jul 2019.
  • 13 Mar 2019 Planned primary completion date changed from 1 Feb 2019 to 1 Jul 2019.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top